6435.TAKASHASHI, M.D., ANRADE Jr., H.F., WAKAMATSU, A.,SIQUEIRA, S., and DE BRITO, T. In<strong>de</strong>teminate leprosy:histopathological and histochemical predictive parameters involvedin its possible change to paucibacillary or multibacillary leprosy. Int.J. Lepr. 59 (1991), 12-19.36.VAN VOORHIS, W.C., KAPLAN, G., SARNO, E.N., HORWITZ,M.A., STEINMAN, R.M., LEVIS, W.R., NOGUEIRA, N., HAIR, L.S.,GATTAS, C.R., ARRICK, B.A., and COHN, Z.A. The cutaneousinfiltrates <strong>of</strong> leprosy: cellular characteristics and predominant T-cellphenotypes. J. Med. 307 (1992) 1593-1597.37.VERHAGEN, C.E, WIERENGA, E.A., BUFFING, A., FABER, W.,KLATSER, P., NAAFS, B., and DAS, P.K. Reversal reaction inbor<strong>de</strong>rline leprosy is associated with a polarized shift to type 1-likeMycobacterium leprae T-cell reactivity in lesional skin. J. Immunol.159 (1997) 1470-1475.38.VERHAGEN, C., FABER, W., KLATSER, P., BUFFING, A., NAAFS,B., and DAS, P. Immunohistological analysis <strong>of</strong> in situ expression <strong>of</strong>mycobacterial antigens in skin lesions <strong>of</strong> leprosy patients across thehistopathological spectrum. Association <strong>of</strong> mycobacteriallipoarabinomannan (LAM) and mycobacterium leprae phenolicglycolipi-I (PGL-I) with leprosy reactions. Am. J. Pathol. 154 (1999)1793-1804.39. WADE, H.W. Tuberculoid changes in leprosy: II. Lepra reaction intuberculoid leprosy. Int. J. Lepr. 2 (1934) 279-292.40.WEISS, E., MAMELAK, A.J., LA MORGIA, S., WANG, B.,FELICIANI, C., TULLI, A., SAUDER, D.N. The role <strong>of</strong> interleukin 10
65in the pathogenesis and potential treatment <strong>of</strong> skin diseases. J. Am.Acad. Dermatol., 50, p.657-675, 2004.41.YAMAMURA, M., UYEMURA, K., DEANS, R.J., WEINBERG, K.,REA T.H., BLOOM, B.R., and MODLIN, RI. Defining protectiveresponses to pathogens: cytokine pr<strong>of</strong>iles in leprosy lesions.Science 254 (1991) 277-279.